$CBRE
CBRE GROUP, INC. Stock $cbre

$cbre Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000113811824000014 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$8.391B	$7.935B
YoY Change	8.69%	7.07%
Cost Of Revenue	$6.793B	$6.475B
YoY Change	9.93%	7.8%
Gross Profit	$1.598B	$1.460B
YoY Change	3.74%	3.94%
Gross Profit Margin	19.04%	18.4%
Selling, General & Admin	$1.140B	$1.111B
YoY Change	4.72%	-8.1%
% of Gross Profit	71.35%	76.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$161.0M	$158.0M
YoY Change	4.28%	-2.16%
% of Gross Profit	10.08%	10.82%
Operating Expenses	$1.301B	$1.269B
YoY Change	4.67%	-7.4%
Operating Profit	$246.0M	$204.0M
YoY Change	-17.22%	445.97%
Interest Expense	-$78.00M	-$94.00M
YoY Change	54.5%	-182.99%
% of Operating Profit	-31.71%	-46.08%
Other Income/Expense, Net	$6.000M	$9.000M
YoY Change	6.91%	263.64%
Pretax Income	$174.0M	$119.0M
YoY Change	-33.48%	-22.28%
Income Tax	$32.00M	-$29.00M
% Of Pretax Income	18.39%	-24.37%
Net Earnings	$130.0M	$126.0M
YoY Change	-35.45%	7.79%
Net Earnings / Revenue	1.55%	1.59%
Basic Earnings Per Share	$0.42	$0.41
Diluted Earnings Per Share	$0.42	$0.41
COMMON SHARES
Basic Shares Outstanding	306.8M shares	305.7M shares
Diluted Shares Outstanding	308.0M shares	308.5M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$928.0M	$1.044B
YoY Change	-26.42%	-15.21%
Cash & Equivalents	$928.0M	$1.044B
Short-Term Investments
Other Short-Term Assets	$357.0M	$365.0M
YoY Change	-67.06%	-40.27%
Inventory
Prepaid Expenses	$342.0M	$308.0M
Receivables	$6.304B	$6.172B
Other Receivables	$1.163B	$1.010B
Total Short-Term Assets	$9.653B	$9.444B
YoY Change	1.94%	4.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$895.0M	$900.0M
YoY Change	-53.67%	8.01%
Goodwill	$5.667B	$5.554B
YoY Change	12.36%	12.57%
Intangibles	$2.385B	$2.298B
YoY Change	11.98%	6.74%
Long-Term Investments	$1.309B	$1.298B
YoY Change	0.17%	0.22%
Other Assets	$1.634B	$1.610B
YoY Change	-0.62%	41.91%
Total Long-Term Assets	$13.81B	$13.52B
YoY Change	12.61%	12.82%
TOTAL ASSETS
Total Short-Term Assets	$9.653B	$9.444B
Total Long-Term Assets	$13.81B	$13.52B
Total Assets	$23.46B	$22.96B
YoY Change	7.96%	9.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.568B	$3.415B
YoY Change	23.62%	13.51%
Accrued Expenses	$2.448B	$2.420B
YoY Change	-6.65%	-6.04%
Deferred Revenue	$311.0M	$304.0M
YoY Change	17.94%	15.95%
Short-Term Debt	$1.908B	$1.666B
YoY Change	20.27%	-16.35%
Long-Term Debt Due	$28.00M	$19.00M
YoY Change	-94.07%	-95.62%
Total Short-Term Liabilities	$8.629B	$8.233B
YoY Change	5.84%	-5.56%
LONG-TERM LIABILITIES
Long-Term Debt	$3.272B	$3.282B
YoY Change	54.08%	202.14%
Other Long-Term Liabilities	$885.0M	$871.0M
YoY Change	-61.21%	-16.63%
Total Long-Term Liabilities	$4.157B	$4.153B
YoY Change	-5.64%	94.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.629B	$8.233B
Total Long-Term Liabilities	$4.157B	$4.153B
Total Liabilities	$14.27B	$13.87B
YoY Change	4.69%	11.93%
SHAREHOLDERS EQUITY
Retained Earnings	$9.384B	$9.263B
YoY Change	4.14%	5.14%
Common Stock	$3.000M	$3.000M
YoY Change	-80.79%	-3.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.356B	$8.261B
YoY Change
Total Liabilities & Shareholders Equity	$23.46B	$22.96B
YoY Change	7.96%	9.2%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$130.0M	$126.0M
YoY Change	-35.45%	7.79%
Depreciation, Depletion And Amortization	$161.0M	$158.0M
YoY Change	4.28%	-2.16%
Cash From Operating Activities	$287.0M	-$492.0M
YoY Change	-2740.78%	-33.94%
INVESTING ACTIVITIES
Capital Expenditures	$67.00M	$68.00M
YoY Change	-10.34%	12.8%
Acquisitions
YoY Change
Other Investing Activities	-$340.0M	-$16.00M
YoY Change	89.39%	292.73%
Cash From Investing Activities	-$407.0M	-$900.0M
YoY Change	60.08%	682.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00M	$1.192B
YoY Change	-84.06%	56.63%
NET CHANGE
Cash From Operating Activities	287.0M	-$492.0M
Cash From Investing Activities	-407.0M	-$900.0M
Cash From Financing Activities	50.00M	$1.192B
Net Change In Cash	-70.00M	-$244.0M
YoY Change	-243.97%	186.86%
FREE CASH FLOW
Cash From Operating Activities	$287.0M	-$492.0M
Capital Expenditures	$67.00M	$68.00M
Free Cash Flow	$220.0M	-$560.0M
YoY Change	-357.02%	-30.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	304889140	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	304889140	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125000000	usd
CY2024Q1	cbre	Convertible Preferred Stock Relevant Measurement Period Following Merger ConvertiblePreferredStockRelevantMeasurementPeriodFollowingMerger	P7Y
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2024Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	3000000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9263000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9188000000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1005000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-924000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8261000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8267000000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	838000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	800000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9099000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9067000000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22964000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22548000000	usd
CY2024Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	1111000000	usd
CY2023Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	1209000000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	158000000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	162000000	usd
CY2024Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	7744000000	usd
CY2023Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	7377000000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	13000000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	204000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	37000000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-58000000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	142000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-36000000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	119000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	153000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-29000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	148000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	22000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	126000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	117000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	305808212	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	310464609	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	308502456	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	315358147	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	148000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-88000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	38000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	5000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-88000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	43000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	60000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	168000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	15000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	22000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	45000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	146000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	148000000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	158000000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	162000000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2000000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1000000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	29000000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	23000000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	13000000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	5000000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3000000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	30000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18000000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-58000000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	142000000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	22000000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	178000000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	2054000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	2167000000	usd
CY2024Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2216000000	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2495000000	usd
CY2024Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	173000000	usd
CY2023Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	335000000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-7000000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-1000000	usd
CY2024Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	11000000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	2000000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	10000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	2000000	usd
CY2024Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	5000000	usd
CY2023Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	6000000	usd
CY2024Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	-244000000	usd
CY2023Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	73000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-211000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-74000000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-824000000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-844000000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	43000000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	57000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	44000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	22000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-492000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-745000000	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	68000000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	60000000	usd
CY2024Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	783000000	usd
CY2023Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	45000000	usd
CY2024Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	28000000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	29000000	usd
CY2024Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	22000000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	15000000	usd
CY2024Q1	us-gaap	Payments To Acquire And Develop Real Estate PaymentsToAcquireAndDevelopRealEstate	59000000	usd
CY2023Q1	us-gaap	Payments To Acquire And Develop Real Estate PaymentsToAcquireAndDevelopRealEstate	0	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-16000000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-900000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115000000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1070000000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1660000000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	250000000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	629000000	usd
CY2024Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	2000000	usd
CY2023Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	0	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	130000000	usd
CY2024Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	8000000	usd
CY2023Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	60000000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	97000000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	46000000	usd
CY2024Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1000000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-21000000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-34000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1192000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	761000000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-44000000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-244000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-85000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1371000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1405000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1127000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1320000000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	100000000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	39000000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	90000000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	82000000	usd
CY2024Q1	cbre	Deferred Purchase Consideration DeferredPurchaseConsideration	11000000	usd
CY2023Q1	cbre	Deferred Purchase Consideration DeferredPurchaseConsideration	0	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9067000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	148000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30000000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	97000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-88000000	usd
CY2024Q1	cbre	Noncontrolling Interest Increase From Contributions NoncontrollingInterestIncreaseFromContributions	1000000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	22000000	usd
CY2024Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-16000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9099000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8606000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18000000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	46000000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	114000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	38000000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-15000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8642000000	usd
CY2024Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Readers of this Quarterly Report on Form 10-Q (Quarterly Report) should refer to the audited financial statements and notes to consolidated financial statements of CBRE Group, Inc., a Delaware corporation (which may be referred to in these financial statements as “CBRE,” “the company,” “we,” “us” and “our”), for the year ended December 31, 2023, which are included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001138118/000113811824000006/cbre-20231231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 Annual Report on Form 10-K (2023 Annual Report)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the United States Securities and Exchange Commission (SEC) and also available on our website (www.cbre.com), since we have omitted from this Quarterly Report certain footnote disclosures which would substantially duplicate those contained in such audited financial statements. You should also refer to Note 2, Significant Accounting Policies, in the notes to consolidated financial statements in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001138118/000113811824000006/cbre-20231231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of our significant accounting policies and estimates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statement Preparation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with the rules applicable to quarterly reports on Form 10-Q and include all information and footnotes required for interim financial statement presentation, but do not include all disclosures required under accounting principles generally accepted in the United States (U.S.), or General Accepted Accounting Principles (GAAP), for annual financial statements. Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S., which require management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts reported in our consolidated financial statements and accompanying notes and are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate. Actual results may differ from these estimates and assumptions.</span></div>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S., which require management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts reported in our consolidated financial statements and accompanying notes and are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate.
CY2023Q4	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	675000000	usd
CY2024Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2216000000	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	8000000	usd
CY2024Q1	cbre	Sale Of Mortgage Loans Held For Sale SaleOfMortgageLoansHeldForSale	2046000000	usd
CY2024Q1	us-gaap	Proceeds From Collection Of Mortgage Loans Held For Sale ProceedsFromCollectionOfMortgageLoansHeldForSale	8000000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	2054000000	usd
CY2024Q1	cbre	Net Increase Decrease In Mortgage Servicing Rights Included In Warehouse Receivables NetIncreaseDecreaseInMortgageServicingRightsIncludedInWarehouseReceivables	3000000	usd
CY2024Q1	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	848000000	usd
CY2024Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	326800000	usd
CY2023Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	352300000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1298000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1374000000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3311000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2824000000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	19000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9000000	usd
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10000000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	11000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3282000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2804000000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1003000000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1030000000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	210000000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	210000000	usd
CY2024Q1	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1213000000	usd
CY2023Q4	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1240000000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	249000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	242000000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	35000000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	36000000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1055000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1089000000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	74000000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	72000000	usd
CY2024Q1	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1413000000	usd
CY2023Q4	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1439000000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	27000000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	40000000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	16000000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	8000000	usd
CY2024Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	2000000	usd
CY2023Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	-53000000	usd
CY2024Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	-2000000	usd
CY2023Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	0	usd
CY2024Q1	cbre	Funded Loan Principal Amount Outstanding FundedLoanPrincipalAmountOutstanding	42100000000	usd
CY2024Q1	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	60700000	usd
CY2023Q4	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	67400000	usd
CY2024Q1	cbre	Assets Available For Recourse AssetsAvailableForRecourse	622900000	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	253700000	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	253700000	usd
CY2024Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	205500000	usd
CY2024Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	205500000	usd
CY2024Q1	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	271100000	usd
CY2023	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	266100000	usd
CY2024Q1	cbre	Investment Funds Maximum Equity In Real Estate Investment Percent InvestmentFundsMaximumEquityInRealEstateInvestmentPercent	0.020
CY2024Q1	cbre	Commitments To Investment In Future Real Estate Investment CommitmentsToInvestmentInFutureRealEstateInvestment	175700000	usd
CY2024Q1	cbre	Real Estate Investments Maximum Equity In Real Estate Investment Percent RealEstateInvestmentsMaximumEquityInRealEstateInvestmentPercent	0.50
CY2024Q1	cbre	Other Commitment Capital Investment In Consolidated Projects OtherCommitmentCapitalInvestmentInConsolidatedProjects	190300000	usd
CY2024Q1	cbre	Other Commitment Capital Investment In Unconsolidated Entity OtherCommitmentCapitalInvestmentInUnconsolidatedEntity	54300000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-28900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-56900000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.243
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.183
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	337200000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	413500000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-76300000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	126000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	117000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	305808212	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	310464609	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	126000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	117000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	305808212	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	310464609	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2694244	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	4893538	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	308502456	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	315358147	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1500000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7807000000	usd
CY2024Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	128000000	usd
CY2024Q1	us-gaap	Revenues Revenues	7935000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7302000000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	109000000	usd
CY2023Q1	us-gaap	Revenues Revenues	7411000000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	549800000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	462200000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	517400000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	442900000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	303500000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	304300000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	297600000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-131800000	usd
CY2024Q1	us-gaap	Revenues Revenues	7935000000	usd
CY2023Q1	us-gaap	Revenues Revenues	7411000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	126000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	117000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	22000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	148000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125000000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	158000000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	162000000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-36000000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-29000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000000	usd
CY2024Q1	cbre	Costs Associated With Efficiency And Cost Reduction Initiatives CostsAssociatedWithEfficiencyAndCostReductionInitiatives	29000000	usd
CY2023Q1	cbre	Costs Associated With Efficiency And Cost Reduction Initiatives CostsAssociatedWithEfficiencyAndCostReductionInitiatives	139000000	usd
CY2024Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	14000000	usd
CY2023Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	7000000	usd
CY2024Q1	us-gaap	Restructuring Costs RestructuringCosts	1000000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2024Q1	cbre	Business Combination Integration Related Costs And Other Net Costs BusinessCombinationIntegrationRelatedCostsAndOtherNetCosts	4000000	usd
CY2023Q1	cbre	Business Combination Integration Related Costs And Other Net Costs BusinessCombinationIntegrationRelatedCostsAndOtherNetCosts	-18000000	usd
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	17500000	usd
CY2024Q1	cbre	Asset Acquisition Consideration Transferred Transaction Cost Reversal Of Previously Recognized Transaction Costs AssetAcquisitionConsiderationTransferredTransactionCostReversalOfPreviouslyRecognizedTransactionCosts	21700000	usd
CY2024Q1	us-gaap	Revenues Revenues	7935000000	usd
CY2023Q1	us-gaap	Revenues Revenues	7411000000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001138118-24-000014-index-headers.html	Edgar Link	pending
0001138118-24-000014-index.html	Edgar Link	pending
0001138118-24-000014.txt	Edgar Link	pending
0001138118-24-000014-xbrl.zip	Edgar Link	pending
cbre-20240331.htm	Edgar Link	pending
cbre-20240331.xsd	Edgar Link	pending
cbre-20240331x10qxex221.htm	Edgar Link	pending
cbre-20240331x10qxex311.htm	Edgar Link	pending
cbre-20240331x10qxex312.htm	Edgar Link	pending
cbre-20240331x10qxex32.htm	Edgar Link	pending
cbre-20240331_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
cbre-20240331_def.xml	Edgar Link	unprocessable
cbre-20240331_lab.xml	Edgar Link	unprocessable
cbre-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cbre-20240331_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cbre-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBRE
CBRE GROUP, INC. Stock $cbre

2024 Q2 Form 10-Q Financial Statement

#000113811824000014 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE CBRE GROUP, INC. Stock $cbre

2024 Q2 Form 10-Q Financial Statement

#000113811824000014 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE
CBRE GROUP, INC. Stock $cbre